Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation
Authors:
- 19 November 2013
- journal article
- Published by Springer Nature in Annals of Hematology
- Vol. 93 (5) , 855-861
Abstract
In a retrospective single-centre study, we analysed the prognostic impact of factors identifiable at initial diagnosis of acute GVHD (aGVHD). We retrospectively analysed 495 adult patients of whom 308 (62 %) developed acute GVHD (I–IV) and were included in further analysis. Gut aGVHD was diagnosed in 163/308 cases (53 %). Conditioning was myeloablative conditioning (MAC) in 123 (39.9 %) and reduced intensity (RIC) in 185 (60.1 %) patients. Median serum albumin level at diagnosis of aGVHD was 34 g/l, which was used as cut-off for low vs. normal albumin levels. In patients with gut aGVHD, low albumin level at the time of diagnosis of aGVHD was associated with poorer overall survival (OS) which was 52 vs. 67 % at 1 year and 40 vs. 61 % at 3 years, p = 0.015. In patients with only skin aGVHD, 1- and 3-year OS of patients with low vs. normal albumin levels were 72 vs. 72 % and 59 vs. 57 %, respectively, p = 0.69. In multivariate analysis of patients with gut aGVHD, low serum albumin level ≤34 g/l (relative risk (RR) 2.13, p = 0.003), gut aGVHD grades 3–4 (RR 2.70, p = 0.001), RIC (RR 1.84, p = 0.024), matched unrelated donor (RR 1.86, p = 0.18) and mismatched unrelated donor (RR 2.76, p = 0.03) retained negative impact on OS. Subgroup analysis revealed that impact of albumin was restricted to patients with gut aGVHD after RIC. Low serum albumin levels are associated with poorer OS in patients with gut but not skin aGVHD after RIC but not MAC allogeneic stem cell transplantation.Keywords
This publication has 26 references indexed in Scilit:
- Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host diseaseBlood, 2012
- Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine TreatmentTransplantation and Cellular Therapy, 2012
- Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseBlood, 2011
- Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalBlood, 2008
- Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2008
- Cytokine profiles in stem cell transplantation: Possible use as a predictor of graft-versus-host diseaseHematology, 2005
- A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, γ glutamyl transferase, donor type and cell doseBone Marrow Transplantation, 2003
- Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systemsTransplantation and Cellular Therapy, 2002
- Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatmentTransplantation and Cellular Therapy, 2002
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990